Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for NRO.PA and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for NRO.PA and 80,000+ other tickers.
See exactly how NRO.PA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for NRO.PA and 80,000+ other tickers.
Neurones S.A., an information technology (IT) services provider founded in 1984 and headquartered in Nanterre, France, operates with a global reach. The company delivers a broad spectrum of services encompassing infrastructure, application development, and strategic consulting. Its infrastructure capabilities include comprehensive management, cloud solutions, user support, DevOps implementation, robust cybersecurity measures, IT service management, system governance, and automation. For applications, Neurones specializes in SAP integration and outsourcing, mobile development, data management…
Nanterre, le 20 avril 2026 Déclaration des transactions sur actions propres(période du 13 au 17 avril 2026) Dans le cadre du programme de rachat d'actions propres autorisé par l'Assemblée Générale du 5 juin 2025 et confié au CIC, NEURONES a procédé, entre le 13 et le 17 avril 2026, aux achats suivants (code ISIN FR0004050250): Au 17 avril 2026, hors contrat de liquidité, NEURONES détient maintenant 381 250 des 24 328 716 actions composant le capital de la société (soit 1,57%).
Nanterre, April 20, 2026 Declaration of transactions on treasury shares(period from April 13 to 17, 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025 and entrusted to CIC, NEURONES made the following purchases between April 13 and 17, 2026 (ISIN code FR0004050250): As of April 17, 2026, excluding the liquidity contract, NEURONES now holds 381,250 of the 24,328,716 shares comprising the company's capital (i.
Nanterre, le 7 avril 2026 Déclaration des transactions sur actions propres(période du 30 mars au 3 avril 2026) Dans le cadre du programme de rachat d'actions propres autorisé par l'Assemblée Générale du 5 juin 2025 et confié au CIC, NEURONES a procédé, entre le 30 mars et le 3 avril 2026, aux achats suivants (code ISIN FR0004050250): Au 3 avril 2026, hors contrat de liquidité, NEURONES détient maintenant 309 613 des 24 328 716 actions composant le capital de la société (soit 1,27%).
Nanterre, April 7, 2026 Declaration of transactions on treasury shares(period from March 30 to April 3, 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025 and entrusted to CIC, NEURONES made the following purchases between March 30 and April 3, 2026 (ISIN code FR0004050250): As of April 3, 2026, excluding the liquidity contract, NEURONES now holds 309,613 of the 24,328,716 shares comprising the company's capital (i.
INFORMATION PRESSERubrique: Résultats annuels 2025 Nanterre, le 11 mars 2026 (après Bourse) Résultat net part du groupe stable en 2025 (1) En millions d'euros, comptes 2025 arrêtés par le Conseil d'Administration du 11 mars 2026.